Trial NCT01773616

View at ClinicalTrials.gov 
Org. Study IDs: CRO2035

Last trial update was posted on 2018-02-01

MeSH Interventions

Methylprednisolone Methylprednisolone Acetate Methylprednisolone Hemisuccinate Mycophenolic Acid Prednisolone Prednisolone acetate Prednisolone hemisuccinate Prednisolone phosphate Rituximab

MeSH Conditions

Lupus Erythematosus, Systemic Lupus Nephritis Nephritis

Other Conditions

Systemic Lupus Erythematosus, Lupus Nephritis

Stopping Reasons

Study assessments for patients recruited continuing per protocol so patients receive a minimum of 6 months follow up. No safety concerns have been raised.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID